Artificial Intelligence in Drug Treatment

被引:28
|
作者
Romm, Eden L. [1 ]
Tsigelny, Igor F. [1 ,2 ]
机构
[1] CureMatch Inc, San Diego, CA 92121 USA
[2] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA
来源
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60 | 2020年 / 60卷
关键词
artificial intelligence; machine learning; deep learning; personalized medicine; drug combination; combination therapy; BLOOD-BRAIN-BARRIER; FEATURE-SELECTION; PREDICTION; IDENTIFICATION; OPTIMIZATION; POLYPHARMACY; DESCRIPTORS; DATABASE;
D O I
10.1146/annurev-pharmtox-010919-023746
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The most common applications of artificial intelligence (AI) in drug treatment have to do with matching patients to their optimal drug or combination of drugs, predicting drug-target or drug-drug interactions, and optimizing treatment protocols. This review outlines some of the recently developed AI methods aiding the drug treatment and administration process. Selection of the best drug(s) for a patient typically requires the integration of patient data, such as genetics or proteomics, with drug data, like compound chemical descriptors, to score the therapeutic efficacy of drugs. The prediction of drug interactions often relies on similarity metrics, assuming that drugs with similar structures or targets will have comparable behavior or may interfere with each other. Optimizing the dosage schedule for administration of drugs is performed using mathematical models to interpret pharmacokinetic and pharmacodynamic data. The recently developed and powerful models for each of these tasks are addressed, explained, and analyzed here.
引用
收藏
页码:353 / 369
页数:17
相关论文
共 50 条
  • [1] Artificial intelligence in drug combination therapy
    Tsigelny, Igor F.
    BRIEFINGS IN BIOINFORMATICS, 2019, 20 (04) : 1434 - 1448
  • [2] Application of Artificial Intelligence in Drug Discovery
    Chopra, Hitesh
    Baig, Atif A.
    Gautam, Rupesh K.
    Kamal, Mohammad A.
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (33) : 2690 - 2703
  • [3] Recent Studies of Artificial Intelligence on In Silico Drug Distribution Prediction
    Tran, Thi Tuyet Van
    Tayara, Hilal
    Chong, Kil To
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [4] Artificial Intelligence for Drug Discovery: AreWe There Yet?
    Hasselgren, Catrin
    Oprea, Tudor I.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2024, 64 : 527 - 550
  • [5] Artificial intelligence to deep learning: machine intelligence approach for drug discovery
    Gupta, Rohan
    Srivastava, Devesh
    Sahu, Mehar
    Tiwari, Swati
    Ambasta, Rashmi K.
    Kumar, Pravir
    MOLECULAR DIVERSITY, 2021, 25 (03) : 1315 - 1360
  • [6] Artificial intelligence for small molecule anticancer drug discovery
    Duo, Lihui
    Liu, Yu
    Ren, Jianfeng
    Tang, Bencan
    Hirst, Jonathan D.
    EXPERT OPINION ON DRUG DISCOVERY, 2024, 19 (08) : 933 - 948
  • [7] The application of artificial intelligence to accelerate G protein-coupled receptor drug discovery
    Nguyen, Anh T. N.
    Nguyen, Diep T. N.
    Koh, Huan Yee
    Toskov, Jason
    MacLean, William
    Xu, Andrew
    Zhang, Daokun
    Webb, Geoffrey I.
    May, Lauren T.
    Halls, Michelle L.
    BRITISH JOURNAL OF PHARMACOLOGY, 2024, 181 (14) : 2371 - 2384
  • [8] A Review on Applications of Artificial Intelligence in Wastewater Treatment
    Wang, Yi
    Cheng, Yuhan
    Liu, He
    Guo, Qing
    Dai, Chuanjun
    Zhao, Min
    Liu, Dezhao
    SUSTAINABILITY, 2023, 15 (18)
  • [9] Enhancing preclinical drug discovery with artificial intelligence
    Vijayan, R. S. K.
    Kihlberg, Jan
    Cross, Jason B.
    Poongavanam, Vasanthanathan
    DRUG DISCOVERY TODAY, 2022, 27 (04) : 967 - 984
  • [10] Artificial intelligence in the treatment of cancer: Changing patterns, constraints, and prospects
    Ali, Mohammad
    Wani, Shahid Ud Din
    Dey, Tathagata
    Mehdi, Seema
    HEALTH AND TECHNOLOGY, 2024, 14 (03) : 417 - 432